Nonopioid Analgesia After Labral Surgery

Status Recruiting

Clinical Trial Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Clinical Trial Description

Study Design: This is a randomized, single blinded, standard of care-controlled clinical trial. All adult patients over eighteen desiring rotator cuff repair will be eligible. Nonnarcotic postoperative pain control regimen described below were chosen based on previous studies in fracture care and joint arthroplasty.

Patients will be consented and recruited. Once participation has been determined and consent obtained, the names of participating patients will be provided to the research pharmacy. Patients will be randomized with a computer-generated table in 2 patient blocks by the research pharmacy. Patients postoperative analgesia will be divided into one of the following 2 treatment arms: 1) A novel nonopioid pain protocol or 2) traditional narcotic pain analgesia

Primary endpoints is reduction in pain as measured by VAS and PROMIS. The endpoints will be collected at each post-operative day using a journal. Moreover, endpoints will be collected at the patient's first post-operative appointment. These appointments are scheduled within one-week of the index procedure.

Statistical Analysis: All continuous data will be analyzed using independent 2-group t tests and reported as means ± standard deviations. Categorical data will be compared between the 2 groups using chi-square tests and reported as counts and percentages. A preliminary test to confirm the quality of variances will be conducted prior to utilizing the t test to confirm the appropriate statistical analysis. Nonparametric equivalents Wilcoxon rank-sum and Fisher exact tests will be used as needed for nonnormal distributions and low variable numbers, respectively. A multivariable regression analysis was performed to assess for potential confounding demographic variables. ;

Study Design

Related Conditions & MeSH terms

Narcotic Use

Clinical Trial Details

NCT number	NCT03825809
Study type	Interventional
Source	Henry Ford Health System
Contact	Toufic R Jildeh, MD
Phone	517-230-8511
Email	tjildeh1@hfhs.org
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	January 22, 2019
Completion date	May 20, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04130464` - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management	Phase 4
Terminated	`NCT03330119` - Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section	Phase 3
Completed	`NCT05592522` - Efficacy of External Oblique Intercostal Block in Laparoscopic Bariatric Surgery	N/A
Withdrawn	`NCT03197311` - A Mobile Application for Post-op Analgesic Consumption	N/A
Completed	`NCT03422211` - A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries
Not yet recruiting	`NCT05611749` - Duloxetine Impact on Postoperative Pain Control and Outcomes	Phase 2
Terminated	`NCT06458842` - Postoperative Pain Protocol Limiting Narcotics for Laparoscopic Hand-assisted Donor Nephrectomy	N/A
Recruiting	`NCT04791943` - Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery	Phase 2
Not yet recruiting	`NCT04305730` - Use of Pedometer Following Radical Cystectomy	N/A
Completed	`NCT02110719` - Decreasing Narcotics in Advanced Pelvic Surgery	Phase 4
Completed	`NCT05758090` - Newborn Infant Parasympathetic Evaluation (NIPE) for Guiding Intraoperative Fentanyl in Children Under 2 Years	N/A
Completed	`NCT04710069` - Postoperative Opt-In Narcotic Treatment Study	N/A
Completed	`NCT04019834` - Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy	Early Phase 1
Completed	`NCT04362566` - Bupivacaine for Post-operative Pain in Mohs	Phase 4
Completed	`NCT03820193` - Nonopioid Analgesia After Arthroscopic Meniscus Surgery	Early Phase 1
Withdrawn	`NCT04444830` - Sprix for Postoperative Pain Control Following Gynecologic Surgery	Phase 4
Completed	`NCT03341533` - Abdominal Ice Packs for Pain Control and Reduction of Narcotic Use Following Laparoscopic Hysterectomy	N/A
Recruiting	`NCT05463367` - Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure	Phase 2
Terminated	`NCT03682367` - Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery	Phase 3
Suspended	`NCT03670914` - Diagnosis of Sleep-Related Respiratory Disorders in Patients With Narcotic Medications	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.